BIOVENTUS INC. Current Federal Tax Expense (Benefit)
BIOVENTUS INC. (BVS) reported Current Federal Tax Expense (Benefit) of -$4.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-03-05
- BIOVENTUS INC. current federal tax expense (benefit) for fiscal 2025 was -$4.20M.
- BIOVENTUS INC. current federal tax expense (benefit) for fiscal 2024 was -$1.29M.
- BIOVENTUS INC. current federal tax expense (benefit) for fiscal 2023 was -$734.00K, a 135.09% decline from fiscal 2022.
- BIOVENTUS INC. current federal tax expense (benefit) for fiscal 2022 was $2.09M, a 63.14% decline from fiscal 2021.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$4.20M 10-K · filed 2026-03-05 |
| 2024-12-31 | -$1.29M 10-K · filed 2026-03-05 |
| 2023-12-31 | -$734.00K 10-K · filed 2026-03-05 |
| 2022-12-31 | $2.09M 10-K · filed 2025-03-11 |
| 2021-12-31 | $5.67M 10-K · filed 2024-03-12 |
| 2020-12-31 | $782.00K 10-K · filed 2023-03-31 |
| 2019-12-31 | $932.00K 10-K · filed 2022-03-11 |